A Hamiltonian Engine for Radiotherapy Optimization.


Journal

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
ISSN: 2694-0604
Titre abrégé: Annu Int Conf IEEE Eng Med Biol Soc
Pays: United States
ID NLM: 101763872

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 27 10 2020
Statut: ppublish

Résumé

We apply a new hardware and software platform called the Hamiltonian Engine for Radiotherapy Optimization (HERO) to the problem of Intensity-Modulated Radiation Therapy (IMRT) treatment planning. HERO solves large general-form binary optimization problems by decomposing them into sub-problems and approximating them using a quadratic pseudo-boolean function. Optimizing the resulting function becomes a quadratic unconstrained binary optimization (QUBO) problem, which has been widely studied and has numerous applications in various fields. A Quantum Annealer (QA) approach has been previously investigated to solve QUBO problems, including IMRT optimization. However, the QA can only accommodate a small number of variables and requires several hours to obtain optimized plans. HERO acts as an optimizer for QUBO problems, which not only addresses these shortcomings but also relies solely on conventional hardware design while operating at room temperature. We evaluate HERO on seven prostate IMRT cases with clinical objectives, each using approximately 6000 beamlets. Our method was compared to the commercial treatment planning software, Eclipse, for both time-to-solution and plan quality. HERO solves most cases in about 30 seconds, with significantly lower objective function scores than Eclipse. The results indicate that HERO is promising for radiation therapy optimization problems. Additionally, HERO has the potential to be applied to Volumetric-Modulated Arc Therapy (VMAT) and other complex types of treatment planning.

Identifiants

pubmed: 33019130
doi: 10.1109/EMBC44109.2020.9175415
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5085-5088

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH